20 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
TGM4 Transglutaminase 4 Cancer-related genes Tissue enriched prostate: 688.5
KLK3 Kallikrein-related peptidase 3 Cancer-related genes Tissue enriched prostate: 12913.7
KLK2 Kallikrein-related peptidase 2 Cancer-related genes Tissue enriched prostate: 850.1
ACPP Acid phosphatase, prostate Cancer-related genes Tissue enriched prostate: 6368.2
RLN1 Relaxin 1 Plasma proteins Tissue enriched prostate: 33.4
KLK4 Kallikrein-related peptidase 4 Cancer-related genes Tissue enriched prostate: 395.8
MSMB Microseminoprotein, beta- Cancer-related genes Tissue enriched prostate: 18712.1
SLC45A3 Solute carrier family 45, member 3 Cancer-related genes Nucleoplasm Tissue enriched prostate: 430.6
CHRNA2 Cholinergic receptor, nicotinic, alpha 2 (neuronal) Disease related genes Tissue enriched prostate: 43.0
NEFH Neurofilament, heavy polypeptide Disease related genes Nucleus Tissue enriched prostate: 484.2
NKX3-1 NK3 homeobox 1 Cancer-related genes Tissue enriched prostate: 517.0
SP8 Sp8 transcription factor Predicted intracellular proteins Nucleus Tissue enriched prostate: 9.8
STEAP2 STEAP family member 2, metalloreductase Predicted intracellular proteins Vesicles Tissue enriched prostate: 205.1
NCAPD3 Non-SMC condensin II complex, subunit D3 Plasma proteins Nucleoplasm Tissue enriched prostate: 175.5
RFPL2 Ret finger protein-like 2 Predicted intracellular proteins Nuclear speckles Tissue enriched prostate: 7.0
RDH11 Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) Disease related genes Tissue enriched prostate: 945.5
TRPM8 Transient receptor potential cation channel, subfamily M, member 8 FDA approved drug targets Tissue enriched prostate: 128.7
OR51E2 Olfactory receptor, family 51, subfamily E, member 2 Cancer-related genes Tissue enriched prostate: 38.9
COL9A1 Collagen, type IX, alpha 1 Disease related genes Tissue enriched prostate: 32.7
SLC30A4 Solute carrier family 30 (zinc transporter), member 4 Plasma proteins Tissue enriched prostate: 64.1
Page
